Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0VS3A
|
|||
Drug Name |
Hydroxyqunoline analog 4
|
|||
Synonyms |
PMID25468267-Compound-44
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C21H23N3O2
|
|||
Canonical SMILES |
CN(C)CCCNC(=O)C1=CC=C(C=C1)C2=CC(=C3C(=C2)C=CC=N3)O
|
|||
InChI |
1S/C21H23N3O2/c1-24(2)12-4-11-23-21(26)16-8-6-15(7-9-16)18-13-17-5-3-10-22-20(17)19(25)14-18/h3,5-10,13-14,25H,4,11-12H2,1-2H3,(H,23,26)
|
|||
InChIKey |
QDBVSOZTVKXUES-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Lysine-specific demethylase 4E (KDM4E) | Target Info | Inhibitor | [1] |
Target's Patent Info | Lysine-specific demethylase 4E (KDM4E) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):135-44. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.